Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Christopher G Proud

Showing results (81-90 of 208) with videos related to

Pageof 21
Sort By:
Adipocyte|August 14, 2020
Identification of DNA response elements regulating expression of CCAAT/enhancer-binding protein (C/EBP) β and δ and MAP kinase-interacting kinases during early adipogenesisJames E Merrett, Tao Bo, Peter J Psaltis, et al.
PNAS Nexus|January 22, 2026
Role of elevation of glycolysis in tumor-associated macrophages in glioblastoma immune evasion and therapeutic implicationsJiezhong Chen, Lin Zhu, Tom Lawson, et al.
Molecular and Cellular Biology|March 16, 2005
Distinct signaling events downstream of mTOR cooperate to mediate the effects of amino acids and insulin on initiation factor 4E-binding proteinsXuemin Wang, Anne Beugnet, Mirei Murakami, et al.
Advances in Biological Regulation|May 24, 2014
Eukaryotic elongation factor 2 kinase, an unusual enzyme with multiple rolesJustin W Kenney, Claire E Moore, Xuemin Wang, et al.
Scientific Reports|February 8, 2019
The ability to utilise ammonia as nitrogen source is cell type specific and intricately linked to GDH, AMPK and mTORC1Shervi Lie, Tingting Wang, Briony Forbes, et al.
The Biochemical Journal|March 11, 2005
Activation of protein synthesis in cardiomyocytes by the hypertrophic agent phenylephrine requires the activation of ERK and involves phosphorylation of tuberous sclerosis complex 2 (TSC2)Mark Rolfe, Laura E McLeod, Phillip F Pratt, et al.
Expert Opinion on Therapeutic Targets|January 18, 2019
The MAP kinase-interacting kinases (MNKs) as targets in oncologyJianling Xie, James E Merrett, Kirk B Jensen, et al.
The Biochemical Journal|July 11, 2020
MAPK-interacting kinase 2 (MNK2) regulates adipocyte metabolism independently of its catalytic activityJames E Merrett, Jianling Xie, Peter J Psaltis, et al.
European Journal of Medicinal Chemistry|April 23, 2021
Progress in developing MNK inhibitorsXin Jin, Rilei Yu, Xuemin Wang, et al.
Molecular and Cellular Biology|February 18, 2003
The C terminus of initiation factor 4E-binding protein 1 contains multiple regulatory features that influence its function and phosphorylationXuemin Wang, Wei Li, Josep-Lluis Parra, et al.
Pageof 21

Showing results (81-90 of 208) with videos related to

Sort By:
Pageof 21
Adipocyte|August 14, 2020
Identification of DNA response elements regulating expression of CCAAT/enhancer-binding protein (C/EBP) β and δ and MAP kinase-interacting kinases during early adipogenesisJames E Merrett, Tao Bo, Peter J Psaltis, et al.
PNAS Nexus|January 22, 2026
Role of elevation of glycolysis in tumor-associated macrophages in glioblastoma immune evasion and therapeutic implicationsJiezhong Chen, Lin Zhu, Tom Lawson, et al.
Molecular and Cellular Biology|March 16, 2005
Distinct signaling events downstream of mTOR cooperate to mediate the effects of amino acids and insulin on initiation factor 4E-binding proteinsXuemin Wang, Anne Beugnet, Mirei Murakami, et al.
Advances in Biological Regulation|May 24, 2014
Eukaryotic elongation factor 2 kinase, an unusual enzyme with multiple rolesJustin W Kenney, Claire E Moore, Xuemin Wang, et al.
Scientific Reports|February 8, 2019
The ability to utilise ammonia as nitrogen source is cell type specific and intricately linked to GDH, AMPK and mTORC1Shervi Lie, Tingting Wang, Briony Forbes, et al.
The Biochemical Journal|March 11, 2005
Activation of protein synthesis in cardiomyocytes by the hypertrophic agent phenylephrine requires the activation of ERK and involves phosphorylation of tuberous sclerosis complex 2 (TSC2)Mark Rolfe, Laura E McLeod, Phillip F Pratt, et al.
Expert Opinion on Therapeutic Targets|January 18, 2019
The MAP kinase-interacting kinases (MNKs) as targets in oncologyJianling Xie, James E Merrett, Kirk B Jensen, et al.
The Biochemical Journal|July 11, 2020
MAPK-interacting kinase 2 (MNK2) regulates adipocyte metabolism independently of its catalytic activityJames E Merrett, Jianling Xie, Peter J Psaltis, et al.
European Journal of Medicinal Chemistry|April 23, 2021
Progress in developing MNK inhibitorsXin Jin, Rilei Yu, Xuemin Wang, et al.
Molecular and Cellular Biology|February 18, 2003
The C terminus of initiation factor 4E-binding protein 1 contains multiple regulatory features that influence its function and phosphorylationXuemin Wang, Wei Li, Josep-Lluis Parra, et al.
Pageof 21